InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Browse the detailed record of transactions filed by Walbert Keli, Director. Director active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 3 disclosures have been logged. Activity tracked since 8 January 2025. The latest transaction was disclosed on 1 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Walbert Keli
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
17,051 sharesCommon StockSEC:0001193125-26-224601:0
7,961 shares0Common StockSEC:0001492422-26-000009:0
9,090 shares0Common StockSEC:0001127602-25-001073:0
3 of 3 declarations
About Walbert Keli
Keli Walbert is a Board Member at Apellis Pharmaceuticals, Inc. She brings significant expertise in corporate governance and strategy. In her role, Keli oversees operations and contributes to strategic decision-making for the company. Her experience in the pharmaceutical sector is an asset for Apellis.
